234 related articles for article (PubMed ID: 31870804)
1. Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy.
Rossi D; Gruart A; Contreras-Murillo G; Muhaisen A; Ávila J; Delgado-García JM; Pujadas L; Soriano E
Prog Neurobiol; 2020 Mar; 186():101743. PubMed ID: 31870804
[TBL] [Abstract][Full Text] [Related]
2. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
[TBL] [Abstract][Full Text] [Related]
3. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
[TBL] [Abstract][Full Text] [Related]
4. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
5. The Role of Reelin Signaling in Alzheimer's Disease.
Yu NN; Tan MS; Yu JT; Xie AM; Tan L
Mol Neurobiol; 2016 Oct; 53(8):5692-700. PubMed ID: 26491027
[TBL] [Abstract][Full Text] [Related]
6. Reelin protects against amyloid β toxicity in vivo.
Lane-Donovan C; Philips GT; Wasser CR; Durakoglugil MS; Masiulis I; Upadhaya A; Pohlkamp T; Coskun C; Kotti T; Steller L; Hammer RE; Frotscher M; Bock HH; Herz J
Sci Signal; 2015 Jul; 8(384):ra67. PubMed ID: 26152694
[TBL] [Abstract][Full Text] [Related]
7. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
8. Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.
Cuchillo-Ibañez I; Balmaceda V; Mata-Balaguer T; Lopez-Font I; Sáez-Valero J
J Alzheimers Dis; 2016 Mar; 52(2):403-16. PubMed ID: 27031488
[TBL] [Abstract][Full Text] [Related]
9. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.
Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB
Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225
[TBL] [Abstract][Full Text] [Related]
10. Age-related accumulation of Reelin in amyloid-like deposits.
Knuesel I; Nyffeler M; Mormède C; Muhia M; Meyer U; Pietropaolo S; Yee BK; Pryce CR; LaFerla FM; Marighetto A; Feldon J
Neurobiol Aging; 2009 May; 30(5):697-716. PubMed ID: 17904250
[TBL] [Abstract][Full Text] [Related]
11. Reelin links Apolipoprotein E4, Tau, and Amyloid-β in Alzheimer's disease.
Yi LX; Zeng L; Wang Q; Tan EK; Zhou ZD
Ageing Res Rev; 2024 Jul; 98():102339. PubMed ID: 38754634
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid impairs reelin signaling.
Cuchillo-Ibáñez I; Balmaceda V; Botella-López A; Rabano A; Avila J; Sáez-Valero J
PLoS One; 2013; 8(8):e72297. PubMed ID: 23951306
[TBL] [Abstract][Full Text] [Related]
13. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.
Chin J; Massaro CM; Palop JJ; Thwin MT; Yu GQ; Bien-Ly N; Bender A; Mucke L
J Neurosci; 2007 Mar; 27(11):2727-33. PubMed ID: 17360894
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications.
Deutsch SI; Rosse RB; Lakshman RM
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1369-80. PubMed ID: 16793187
[TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
[TBL] [Abstract][Full Text] [Related]
16. Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's disease.
Deutsch SI; Rosse RB; Deutsch LH
Eur Neuropsychopharmacol; 2006 Dec; 16(8):547-51. PubMed ID: 16504486
[TBL] [Abstract][Full Text] [Related]
17. The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease.
Cuchillo-Ibañez I; Mata-Balaguer T; Balmaceda V; Arranz JJ; Nimpf J; Sáez-Valero J
Sci Rep; 2016 Aug; 6():31646. PubMed ID: 27531658
[TBL] [Abstract][Full Text] [Related]
18. Reelin, tau phosphorylation and psychiatric complications in patients with hippocampal sclerosis and structural abnormalities in temporal lobe epilepsy.
Machado RA; Benjumea-Cuartas V; Zapata Berruecos JF; Agudelo-Flóres PM; Salazar-Peláez LM
Epilepsy Behav; 2019 Jul; 96():192-199. PubMed ID: 31150999
[TBL] [Abstract][Full Text] [Related]
19. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of melatonin on soluble Aβ
Hu C; Wang P; Zhang S; Ren L; Lv Y; Yin R; Bi J
Neurol Res; 2017 Jul; 39(7):621-631. PubMed ID: 28385118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
